Status:

NOT_YET_RECRUITING

Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

Stichting ParkinsonNL

ZonMw: The Netherlands Organisation for Health Research and Development

Conditions:

Parkinson Disease

Prodromal Stage

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The goal of this clinical trial is two-fold. First to investigate the feasibility of whether a remotely administered smartphone app can increase the volume and intensity of physical activity in daily ...

Detailed Description

Rationale: Parkinson's Disease (PD) is the fastest growing neurodegenerative disease. Exercise beneficially effects motor symptoms and neuroplasticity in people with PD. However, disease-slowing inter...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • previously identified LRRK2 G2019S or GBA N370S variant based on genotyping
  • aged 50 years or older
  • able to understand the English language
  • being able to walk independently inside the home without the use of a walking aid
  • in possession of a suitable smartphone (screen size minimum 4.6 inch), (Android version 9 or iOS version 15 or newer)
  • Not in a high physical activity range during the 4-week eligibility and baseline period
  • Exclusion criteria
  • clinically diagnosed or self-reported diagnosis neurodegenerative disease
  • self-reported falls of three or more per year
  • dexterity problems or cognitive impairments hampering smartphone use
  • if they are not aware of and do not wish to be informed about an increased risk of developing diseases associated with the LRRK2 or GBA1 risk variant
  • if individual is not community-dwelling
  • in possession of one of the following devices: Huawei P8 Lite; Huawei P9 Lite; Xiaomi Mi 6; Huawei P20 Lite (Fitbit is incompatible)

Exclusion

    Key Trial Info

    Start Date :

    July 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 30 2029

    Estimated Enrollment :

    600 Patients enrolled

    Trial Details

    Trial ID

    NCT06993142

    Start Date

    July 1 2025

    End Date

    June 30 2029

    Last Update

    June 3 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University of Rochester Center for Health and Technology (CHeT)

    Rochester, New York, United States, 14642

    2

    Radboud University Medical Center

    Nijmegen, Gelderland, Netherlands, 6525 GA